U.S. Tech Hardware Stock News

NYSE:COF
NYSE:COFConsumer Finance

How Investors Are Reacting To Capital One (COF) Credit Card Rate Cap Risks And Stress Test Buffer

In recent days, Capital One Financial has faced renewed attention on consumer lending and credit trends, alongside Federal Reserve stress test results confirming its 4.5% stress capital buffer will stay in place until September 30, 2027. At the same time, growing regulatory debate over possible caps on US credit card interest rates is adding uncertainty to Capital One’s core card and lending franchise, even as it invests in technology, advisory services, and financial literacy initiatives...
NYSE:SUN
NYSE:SUNOil and Gas

Sunoco (SUN) Could Be 10% Undervalued Following Its Acquisition Driven Growth Story

Sunoco (SUN) is in focus after its recent share performance, with the stock closing at $66.50 and showing mixed returns over the past week, month, and past 3 months that invite closer attention. See our latest analysis for Sunoco. The recent 2.75% 1 day share price return adds to Sunoco’s positive trend, with a 26.11% year to date share price return and a 5 year total shareholder return of 147.78% pointing to momentum that long term holders will be watching closely. If Sunoco’s move has you...
NYSE:MOS
NYSE:MOSChemicals

Did Improved Sulfur Supply and Analyst Upgrade Just Shift Mosaic's (MOS) Investment Narrative?

Recently, analysts at Freedom Broker upgraded The Mosaic Company following an improvement in sulfur supply tied to a US–Iran agreement, while other brokers highlighted rising input costs across the fertilizer industry that are affecting producers’ margins. The focus on sulfur availability is important because sulfur is a critical input for phosphate fertilizer production, meaning supply improvements can materially influence Mosaic’s cost base and profitability prospects. We’ll now examine...
NYSE:ATI
NYSE:ATIAerospace & Defense

ATI (ATI) Could Be 10% Overvalued As Its Strong Run Tests Fair Value

ATI (ATI) has drawn attention after recent trading, with the stock closing at US$197.40 and showing mixed short term moves, including a decline over the past week and gains over the past month. See our latest analysis for ATI. Zooming out, ATI’s recent pullback sits within a strong run, with a 30 day share price return of 12.7% and a year to date share price return of 65.6%. The 1 year total shareholder return of 127.42% points to momentum that has so far been rewarded by the market. If ATI’s...
NYSE:GTY
NYSE:GTYRetail REITs

Is Getty Realty (GTY) Still Undervalued On Strong Occupancy And Lease Visibility?

Getty Realty Stock Overview After Recent Performance Shift Getty Realty (GTY) has drawn fresh attention after a period of positive share performance, with the stock up over the past month and past 3 months, prompting investors to revisit its fundamentals and income profile. See our latest analysis for Getty Realty. Beyond the recent monthly gains, Getty Realty’s share price return of 23.37% year to date and 31.26% total shareholder return over one year point to building momentum as investors...
NYSE:RACE
NYSE:RACEAuto

Ferrari (NYSE:RACE) Replaced Its Marketing Chief After Luce EV Backlash

Ferrari (NYSE:RACE) has replaced its long-serving marketing chief following strong backlash to its first electric vehicle, the Luce. The shake-up comes soon after the Luce launch, as criticism of the model’s positioning and design triggered internal review. The change signals management focus on how Ferrari presents its EV plans to customers and investors. Ferrari, best known for its high performance sports cars and racing heritage, is under closer scrutiny as the auto industry pushes...
NYSE:SJM
NYSE:SJMFood

Conagra Stock And 2 Snack Food Picks For Affordable Treat Demand

Affordable treats are drawing steady foot traffic even as broader US consumer confidence stays weak. That mix of resilient demand and rising input costs is creating a very specific test for confectionery and snack food stocks. With specialty candies, imported sweets, and neighborhood shops all facing higher tariffs, shipping expenses, and supply risks, some companies may be better positioned than others to handle pricing and product availability. This article looks at three stocks exposed to...
NasdaqGS:PLMR
NasdaqGS:PLMRInsurance

Palomar Holdings (PLMR) Could Be 18% Undervalued Following Its Strong Q1 Revenue Beat

Palomar Holdings (PLMR) drew investor attention after reporting Q1 revenue growth of 59.7% year on year and a 5.8% beat versus analyst expectations, with shares rising about 5% to around $116.30. See our latest analysis for Palomar Holdings. The recent Q1 beat comes on top of a 7.2% 1 day share price return and a 13.1% 7 day share price return, although Palomar Holdings’ 1 year total shareholder return is down 17.6% after a very large 3 year total shareholder return of about 7x. If strong...
NYSE:EMN
NYSE:EMNChemicals

Eastman Chemical (EMN) Recycling Gains Raise The Question Of Whether Shares Are A Bargain

Recycling earnings and dividend track record move into focus Eastman Chemical (EMN) is drawing fresh attention after its Kingsport methanolysis facility contributed an additional $60 million in earnings in 2025, with another $30 million targeted for 2026, while the company extends a 16-year streak of dividend increases. See our latest analysis for Eastman Chemical. At a share price of $70.71, Eastman Chemical has a year to date share price return of 9.9%, while its 1 month share price return...
NYSE:GEV
NYSE:GEVElectrical

Why GE Vernova (GEV) Is Down 5.8% After Joining Russell Top 50 And Securing US$2.4 Billion In AI Data Center Orders

In late June 2026, GE Vernova Inc. (NYSE:GEV) was added to the Russell Top 50 Index, following earlier disclosure that it secured about US$2.40 billion in data center equipment orders in the first quarter of 2026 amid rising electrification and grid-modernization demand. This combination of index inclusion and large AI-related power infrastructure orders highlights how GE Vernova is becoming a central supplier to the electricity demands behind data center growth. We will now examine how GE...
NasdaqGS:WIX
NasdaqGS:WIXIT

How Wix’s Microsoft 365 Copilot Integration Could Reshape Wix.com (WIX) Investors’ AI Monetization Story

Earlier this month, Wix.com Ltd. announced a collaboration with Microsoft Corporation to integrate its Wix Harmony website creation tools directly into Microsoft 365 Copilot, allowing users to generate and manage feature-rich Wix sites via natural-language prompts inside the Microsoft 365 interface. This move effectively embeds Wix's broader ecosystem, covering commerce, scheduling, payments, analytics, and more, into everyday productivity workflows, potentially deepening its reach among...
NYSE:MO
NYSE:MOTobacco

Does Altria (MO) Risk Its Legacy Cash Engine by Doubling Down on Smoke-Free Products?

In recent months, Altria Group has responded to pressure on its traditional cigarette business and tighter regulation by accelerating investment in smoke-free alternatives, particularly oral nicotine pouches, while still maintaining its dividend and share repurchase program. This combination of funding reduced-risk products with cash flows from legacy brands, alongside continued capital returns, highlights how Altria is trying to realign its business model without disrupting shareholder...
NasdaqGS:PEP
NasdaqGS:PEPBeverage

PepsiCo Stock And Other Consumer Staples For Defensive Income

With the U.K. economy slipping 0.1% in April 2026 and war driven energy costs squeezing both households and businesses, many investors are rethinking how much risk sits in their portfolios. Defensive Consumer Staples Stocks can sometimes offer a steadier ride when growth cools and rate cuts look distant, but not all stocks respond to the same news in the same way. This article looks at three stocks from a Defensive Consumer Staples Stocks screener that appear positively exposed to the latest...
NYSE:FLR
NYSE:FLRConstruction

Fluor (FLR) Could Be 6% Above Fair Value After New Healthcare Project Wins

Fluor stock: new healthcare infrastructure mandate from Voyageur Fluor (FLR) stock is in focus after Voyageur Pharmaceuticals engaged the company to run feasibility studies for two radiology contrast drug projects tied to Bayer backed iodine and barium manufacturing plans. See our latest analysis for Fluor. Fluor's latest healthcare infrastructure mandate comes after a strong run, with a 30 day share price return of 17.22% and a 5 year total shareholder return of 208.63%, suggesting momentum...
NasdaqGS:IONS
NasdaqGS:IONSBiotechs

Ionis (IONS) Wins Tryngolza Approval And Recordati Deal For Zilganersen

Ionis Pharmaceuticals (NasdaqGS:IONS) received FDA approval for Tryngolza (olezarsen) as the first treatment to reduce triglycerides and the risk of acute pancreatitis in adults with severe hypertriglyceridemia. The company plans a U.S. commercial launch of Tryngolza next month, targeting high risk patients with limited existing options. Ionis also signed a licensing agreement granting Recordati exclusive rights to develop and commercialize zilganersen for Alexander disease outside the U.S.,...
NasdaqGS:ROST
NasdaqGS:ROSTSpecialty Retail

Ross Stores (ROST) Is Still Winning Inflation Weary Shoppers In Store

Ross Stores (NasdaqGS:ROST) is drawing inflation weary shoppers across income brackets with its value focused, off price model. The company is seeing sustained interest in its brick and mortar stores even as many retailers emphasize digital channels. This contrast highlights Ross Stores' differentiated approach at a time when in person discount shopping continues to appeal to budget conscious consumers. Ross Stores runs an off price retail model built around in store treasure hunt style...
NasdaqGS:ALHC
NasdaqGS:ALHCHealthcare

Healthcare Stocks Investors Are Watching For Stability As The Jobs Market Softens

With markets watching a softer May jobs report, muted hiring, elevated layoffs, and a Federal Reserve that may be reluctant to shift rates quickly, many investors are taking a fresh look at stocks that could hold up when growth feels less certain. This article focuses on three stocks from a Defensive Sectors screener, all from Utilities, Consumer Staples, and Healthcare, that are directly exposed to the latest labor market news. Each has been selected for financial strength within its sector,...
NasdaqGS:GLXY
NasdaqGS:GLXYCapital Markets

Galaxy Digital (NasdaqGS:GLXY) And The Tokenization Story Behind Its Fair Value Gap

Recent Share Performance and Business Mix Galaxy Digital (GLXY) has seen mixed share performance recently, with the stock up 3.5% over the past day but down 14.4% over the past week and about 1.1% over the past month. Over the past 3 months, Galaxy Digital is up about 70.6%, with a total return of 46.5% over the past year and a very large gain across the past 3 years. Year to date, the stock is up 18.2%. The company reports annual revenue of US$58,713.02, primarily from its Digital Assets...
NasdaqGM:USAR
NasdaqGM:USARMetals and Mining

USA Rare Earth (USAR) Plans Brazilian Mine Deal To Lock In Non Asian Feedstock

USA Rare Earth (NasdaqGM:USAR) plans to acquire a producing mine in Brazil, with completion targeted for 2026. The company intends to integrate the mine's output into its global value chain to secure non Asian rare earth feedstock. This development is separate from the recent Wheat Ridge facility commissioning and focuses on expanding upstream supply. USA Rare Earth is drawing fresh attention as it moves to add a producing Brazilian mine to its portfolio, reinforcing its role in rare earth...
NasdaqGS:CPB
NasdaqGS:CPBFood

Is Campbell's (CPB) Gluten Free Pivot Quietly Redefining Its Core Brand and Investor Story?

In June 2026, Campbell’s and Banza launched a new gluten free condensed Chicken Noodle Soup made with chickpea penne pasta, while Campbell’s also announced upcoming retirements and internal promotions in its transformation and communications leadership, and the stock was added to the Russell Small Cap Comp Value Index. This combination of a milestone gluten free product aimed at health-conscious consumers, leadership transitions, and fresh index inclusion highlights how Campbell’s is...
NasdaqGS:LAUR
NasdaqGS:LAURConsumer Services

Laureate Education (LAUR) Could Be 54% Undervalued On Weak Enrollment And Cash Flow Concerns

Recent commentary on Laureate Education (LAUR) centers on weak student enrollment growth, flat earnings per share and disappointing free cash flow projections, which raise questions about demand, operational efficiency and the downside risks already reflected in the stock price. See our latest analysis for Laureate Education. At a share price of $37.12, Laureate Education has a 1 month share price return of 16.04% and a 1 year total shareholder return of 60.69%. This puts recent momentum...
NYSE:AMPY
NYSE:AMPYOil and Gas

Cheniere Energy Stock And 2 US Energy Names Tied To Gulf Export Demand

Fresh headlines around potential changes to US sanctions on Venezuela have put US oil refiners back in focus, as traders weigh what cheaper heavy crude access could mean for costs, margins, and long term capital plans. This article looks at how that news ties into a curated screener of larger, financially healthier US refining companies, and why the shift in Venezuelan exports away from China toward the US matters for anyone watching energy stocks. Below, you will see 3 stocks from this...
NasdaqGS:UFCS
NasdaqGS:UFCSInsurance

Why United Fire Group (UFCS) Is Up 8.8% After Earnings Beat And Top Analyst Ranking - And What's Next

In recent months, United Fire Group reported earnings that exceeded expectations and earned a top analyst ranking, highlighting resilient operations and disciplined execution. This combination of positive earnings surprise and attractive value metrics has drawn fresh investor attention to a business already focused on underwriting discipline and expense control. We’ll now examine how this earnings beat and value appeal may influence United Fire Group’s existing investment narrative and...
NasdaqGS:PRAX
NasdaqGS:PRAXBiotechs

Praxis Precision Medicines (PRAX) Is Up 16.1% After FDA Grants Breakthrough Tag To Elsunersen

Earlier this week, Praxis Precision Medicines announced that the FDA granted Breakthrough Therapy Designation to elsunersen (PRAX-222) for treating seizures in children with SCN2A developmental and epileptic encephalopathy caused by gain-of-function SCN2A variants, based on positive EMBRAVE Part A trial data. The designation, layered on top of multiple US and European rare disease incentives, underscores elsunersen’s potential to address a severe epilepsy with no approved genetically...